Introduction {#s1}
============

Ubiquitination plays a prominent role in the signaling cascades of many plant hormones ([@bib35]), such as auxins ([@bib34]), jasmonates ([@bib28]), gibberellins ([@bib47]), and strigolactones ([@bib26]), but also in many plant developmental processes and responses to stress ([@bib38]). Therefore, a very tight control of this process and a high substrate specificity, which is mainly determined by the E3 ubiquitin ligases ([@bib38]), are required. The tremendous diversity of the ubiquitination system and its potential in post-translational regulation are illustrated by the presence of more than 1400 genes that encode E3 ligases in Arabidopsis ([@bib46]). Furthermore, there is a high diversity of ubiquitination types and combinations with other post-translational modifications (PTMs) ([@bib6]; [@bib39]), as well as of the fate of the ubiquitinated protein, such as degradation, delocalization or changes in activity ([@bib39]).

In contrast to the more intensively studied action of E3 ligases, insights into the specific roles of deubiquitination enzymes (DUBs) in plant growth and development are only recently emerging. DUBs can generate free ubiquitin from tandem-linear repeats ([@bib5]; [@bib4]), are able to trim ubiquitin chains by hydrolyzing the isopeptide bond between ubiquitin molecules, and can remove covalently bound ubiquitin from proteins ([@bib22]). The Arabidopsis genome codes for around 50 DUBs. As in yeast and mammals, they can be divided into five classes: the ubiquitin C-terminal hydrolases (UHCs), JAB1/MPN/MOV34 (JAMM) domain DUBs that are zinc metalloproteases, ovarian tumor proteases, the Machado-Josephin domain (MJD) DUBs, and the ubiquitin binding proteins (UBPs), which is the largest group ([@bib18]). All UBPs contain specific catalytic Cys- and His-boxes, which are highly conserved in both sequence and length ([@bib50]). Based on their sequence homology and protein domain organization, these 27 members can be further divided into 14 subfamilies ([@bib49]). UBP12 and UBP13 are the largest UBPs and contain a unique meprin and TRAF homology (MATH) domain. They were first reported to be functional deubiquitinating enzymes that negatively regulate plant immunity ([@bib15]). Since then, both proteins have been described to be involved in diverse molecular pathways. Mutations in *UBP12* and *UBP13* result in early flowering and a decreased periodicity of circadian rhythm ([@bib9]). Molecularly, GIGANTEA (GI) recruits UBP12 and UBP13 to the ZEITLUPE (ZTL) photoreceptor complex, which antagonizes the E3 ligase activity of ZTL and hereby stabilizes GI, ZTL and TOC1 \[TIMING OF CAB (CHLOROPHYLL A/B-BINDING PROTEIN EXPRESSION) 1\] protein levels ([@bib23]). In addition, UBP12 and UBP13 can regulate the expression of several genes by deubiquitinating ubiquitinated H2A (H2Aub) upon associating with LIKE HETEROCHROMATIN PROTEIN 1, a plant-specific polycomb group (PcG) protein ([@bib10]). Polyubiquitination of MYC2 by the PUB10 E3 ligase can be counteracted by UBP12 and UBP13, preventing degradation of MYC2 by the 26S proteasome which then activates jasmonic acid signaling ([@bib19]). In a similar manner, ROOT GROWTH FACTOR RECEPTOR 1 (RGFR1) and ORESARA 1 (ORE1) are deubiquitinated and therefore stabilized by UBP12 and UBP13, leading to an increased root sensitivity to the RGF1 peptide hormone ([@bib1]) and an acceleration in leaf senescence ([@bib30]), respectively.

Mutations in *UBP12* or *UBP13* decrease rosette leaf number and double mutants display severe developmental defects ([@bib9]). However, a direct link between these deubiquitinating enzymes and leaf growth and development remains elusive. Here, we found that UBP12 and UBP13 interact with DA1, DAR1 and DAR2 in vivo. DA1, DAR1 and DAR2 have previously been documented to negatively regulate leaf growth. Upon multiple mono-ubiquitination by BIG BROTHER (BB) or DA2, these latent peptidases are activated to cleave growth regulators, such as UBP15, TCP14, TCP15 and TCP22 ([@bib12]). In addition, the activating E3 ligases BB and DA2 are cleaved and BB is subsequently degraded by the N-degron pathway, mediated by PROTEOLYSIS 1 (PRT1) ([@bib12]). Single knock-outs in *DA1*, *DAR1* and *DAR2* only have very subtle effects on organ size ([@bib12]; [@bib24]). Plant growth is however strongly enhanced in the double mutant *da1ko_dar1-1*, comparable to *da1-1* mutants, which carry a point mutation (DA1^R358K^) ([@bib24]). The latter mutation has a dominant-negative action towards DA1 and DAR1 ([@bib24]) and causes a reduction in peptidase activity ([@bib12]). Rosette growth is however severely impaired in the triple mutant *da1ko_dar1-1_dar2-1*, and the size of leaf cells and the extent of endoreduplication are reduced ([@bib31]). This phenotype can be complemented by ectopic expression of *DA1*, *DAR1* or *DAR2*, suggesting they work redundantly in leaves ([@bib31]). On the other hand, overexpression of *GFP-DA1* results in smaller organs with fewer cells ([@bib44]). Mutants of *UBP15* can abolish the *da1-1* phenotype and give rise to smaller organs ([@bib14]). Inversely, ectopic expression of *UBP15* enhances growth ([@bib14]; [@bib25]).

Here, we demonstrate that UBP12 and UBP13 not only bind DA1, DAR1 and DAR2, but can also remove ubiquitin from these proteins, rendering them in an inactive state. Moreover, UBP12 and UBP13 were not found to be proteolytically cleaved by DA1, DAR1 or DAR2, indicating they work upstream in this pathway. In line with these findings, *UBP12* and *UBP13* mutants and overexpression lines exhibit macroscopic, cellular and molecular phenotypes overlapping with those of *35S::GFP-DA1* overexpression lines and *da1ko_dar1-1_dar2-1* mutants, respectively. Our data provide evidence for a pivotal role of UBP12 and UBP13 in restricting the protease activity of DA1, DAR1 and DAR2 during plant growth and development.

Results {#s2}
=======

DA1, DAR1 and DAR2 interact with UBP12 and UBP13 in vivo {#s2-1}
--------------------------------------------------------

Genetic modifier screens previously identified several interactors of DA1 that either activate its peptidase activity or are subjected to proteolytic cleavage by DA1. To gain further insights into the DA1 growth-regulatory pathway, we generated Arabidopsis lines that overexpressed GFP-tagged fusion proteins of DA1, DAR1 and DAR2. Total protein extracts were isolated from eight-day-old seedlings and incubated with anti-GFP beads to purify the bait proteins and their interactors. Label free quantification identified a significant enrichment (p-value\<0.01) of the UBIQUITIN-SPECIFIC PROTEASE 12 (UBP12) and UBP13 in the GFP-DA1 and GFP-DAR1 samples ([Figure 1A--B](#fig1){ref-type="fig"}) among other interaction candidates ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). Despite the much lower levels of DAR2 MS/MS counts and a lower DAR2 bait protein coverage ([Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}), we found a significant enrichment of UBP12 at a less stringent threshold (p-value\<0.05) and UBP13 at the border of significance ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). To confirm this interaction, we performed an in vitro pull-down using UBP12 and UBP13 as bait proteins. DA1, DAR1 and DAR2 were expressed and isolated as HIS-MBP fusion proteins and UBP12 and UBP13 as GST fusion proteins; free GST was used as a negative control. We incubated equal amounts of free GST, full-length GST-UBP12 and GST-UBP13 with HIS-MBP-DA1, HIS-MBP-DAR1 and HIS-MBP DAR2. Western blot analysis after purification with anti-GST beads showed that HIS-MBP-DA1, HIS-MBP-DAR1 and HIS-MBP-DAR2 could be co-purified with either GST-UBP12 or GST-UBP13, but not with free GST ([Figure 1D--F](#fig1){ref-type="fig"}). Additionally, we co-expressed RFP-DA1, RFP-DAR1 and RFP-DAR2 with either GFP-UBP12 or free GFP from the same vector in Arabidopsis cell suspension cultures. Again, we could confirm the interaction between GFP-UBP12 and RFP-DA1, RFP-DAR1 or RFP-DAR2 ([Figure 1G](#fig1){ref-type="fig"}).

![UBP12 and UBP13 interact with DA1, DAR1 and DAR2.\
(**A--C**) Enrichment of the bait, UBP12 and UBP13 compared to the control after immunoprecipitation in (**A**) *35S::GFP-DA1* (FDR = 0.01, S0 = 1, permutation-based FDR-corrected t-test, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}), (**B**) *35S::GFP-DAR1* (FDR = 0.01, S0 = 1, permutation-based FDR-corrected t-test, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}) or (**C**) *35S::GFP-DAR2* (FDR = 0.05, S0 = 1, permutation-based FDR-corrected t-test, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}) seedlings. (**D--F**) In vitro pull down of (**D**) HIS-MBP-DA1, (**E**) HIS-MBP-DAR1 and (**F**) HIS-MBP-DAR2 with free GST, GST-UBP12 and GST-UBP13. (**G**) In vivo pull-down of RFP-DA1, RFP-DAR1 and RFP-DAR2 with free GFP and GFP-UBP12.\
Figure 1---source data 1.List of DA1, DAR1, DAR2 interactors and LFQ intensities by MS/MS.\
Figure 1---source data 2.MS/MS counts of DA1, DAR1 and DAR2; protein coverage of DA1, DAR1 and DAR2; relative expression levels of *DA1*, *DAR1*, *DAR2*, *UBP12* and *UBP13* during leaf development.](elife-52276-fig1){#fig1}

Next, we measured the expression levels of *DA1*, *DAR1*, *DAR2*, *UBP12* and *UBP13* in isolated wild-type (Col-0) leaves in a detailed time-course from leaf primordium initiation to maturity. Both *UBP12* and *UBP13* are highly and evenly expressed throughout leaf development at comparable levels ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Also *DA1*, *DAR1* and *DAR2* are expressed during leaf development as demonstrated before ([@bib31]), albeit *DAR2* at a lower level ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Previous research showed that UBP12 and UBP13 are localized in the nucleus and cytoplasm ([@bib9]). Additional transient expression of GFP-UBP12 or GFP-UBP13 in *Nicotiana benthamiana* leaves demonstrated that these proteins co-localize in the cytoplasm and the nucleus with RFP-DA1, RFP-DAR1 and RFP-DAR2 ([Figure 1---figure supplements 5](#fig1s5){ref-type="fig"}--[10](#fig1s10){ref-type="fig"}). Taken together, UBP12 and UBP13 co-localize with DA1, DAR1 and DAR2, are co-expressed during leaf development and interact with DA1, DAR1 and DAR2 in vivo and in vitro.

Miss-expression of *UBP12* and *UBP13* alters leaf size {#s2-2}
-------------------------------------------------------

Because DA1, DAR1 and DAR2 are known to restrict plant organ growth, we examined the role of UBP12 and UBP13 in regulating leaf size by generating several independent transgenic *35S::UBP12* and *35S::UBP13* lines. All overexpression lines showed a reduction in rosette area ([Figure 2A](#fig2){ref-type="fig"}). In addition, leaves appeared to be rounder than those of Col-0, a phenotype that can also be observed in *da1-1* plants, and the petioles were found to be shorter. To quantify this, we measured the leaf blade height and width of Col-0, *da1-1*, *35S::UBP12* and *35S::UBP13* plants and calculated the leaf blade index, which is the ratio of leaf height to width and hence a measure of leaf shape ([@bib40]). We could observe a significantly lower leaf blade index in *da1-1* mutants ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and in two independent *35S::UBP12* and *35S::UBP13* lines compared to Col-0 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), meaning the leaves had a rounder shape. For several *35S::UBP13* lines, we were unable to produce stable seed stocks because the homozygous plants were stunted in growth ([Figure 2A](#fig2){ref-type="fig"}) and failed to produce a flower stalk and seeds. We continued with two independent lines for further phenotypic analysis: two homozygous *UBP12* lines (*35S::UBP12_3.1* and *35S::UBP12_3.2*) and two *UBP13* lines from which heterozygous plants were selected (*35S::UBP13_1.1* and *35S::UBP13_2.3*) ([Figure 2A](#fig2){ref-type="fig"}). These lines all had a significant increase in their respective transgene expression compared to Col-0 ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

![Regulation of leaf size by UBP12 and UBP13.\
(**A**) Twenty-one-day-old plants of Col-0, *da1-1* and homozygous (+/+) or heterozygous (+/-) *UBP12* and *UBP13* overexpression lines. Scale bar represents 1 cm, homozygous and heterozygous plants of the same single locus line are linked in the figure. (**B**) Leaf area measurements of Col-0 and *ubp12-2*, n = 3 biological repeats with \>10 plants per repeat. (**C**) Percentage differences of leaf area, cell area and cell number of *ubp12-2*, *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_3.2* compared to Col-0, n = 3 biological repeats with three representative leaves per repeat. (**D**) Relative frequencies of LN transformed cell area distribution of Col-0, *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_3.2* in 1-µm^2^ bin sizes, n = 3 biological repeats with three representative leaves per repeat. Bars represent the SEM; \* indicates p-value\<0.05, ANOVA ([Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}).\
Figure 2---source data 1.Leaf area analysis and statistics of Col-0 and *ubp12-2*; leaf area analysis and statistics of Col-0, *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_3.2*; cellular analysis and statistics of Col-0, *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_3.2*; cellular analysis of *ubp12-2*, relative frequency of the pavement cell area and statistics of Col-0, *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_3.2*.\
Figure 2---source data 2.Q-RT-PCR data and statistics of *UBP12* and *UBP13* expression in Col-0, *da1-1*, *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_3.2* overexpression lines; leaf area data and statistics of *ubp12-1*; leaf area data and statistics of *ubp13-1*; leaf area data and statistics of *ubp13-2*; leaf area data and statistics of *ubp13-3*; relative frequency of *ubp12-2* pavement cell area data and statistics.](elife-52276-fig2){#fig2}

In parallel, we screened two independent *UBP12* T-DNA insertion lines \[*ubp12-1* (GABI_244E11) and *ubp12-2* (GABI_742C10)\] and three independent *UBP13* T-DNA lines \[*ubp13-1* (SALK_128312), *ubp13-2* (SALK_024054) and *ubp13-3* (SALK_132368)\]. After leaf area measurements, we could observe a decrease in leaf area in the *ubp12-2* mutants ([Figure 2B](#fig2){ref-type="fig"}), in which the levels of both *UBP12* and *UBP13* transcripts were previously shown to be downregulated ([@bib9]). Mutant lines in which only the expression of either *UBP12* or *UBP13* was downregulated, displayed no differences in leaf size compared to the control ([Figure 2---figure supplements 4](#fig2s4){ref-type="fig"}--[7](#fig2s7){ref-type="fig"}).

The final leaf size is determined by cell proliferation and cell expansion. To identify which of these processes were affected in the *ubp12-2* mutant and in the *UBP12* and *UBP13* overexpression lines, we performed a cellular analysis on the abaxial pavement cells of mature leaves. In all overexpression lines, the significant decrease in leaf area (29%, 26%, 33% and 36% for *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_2.3*, respectively) was caused by a strong reduction in cell area (26%, 40%, 24% and 46% for *35S::UBP12_3.1*, *35S::UBP12_3.2*, *35S::UBP13_1.1* and *35S::UBP13_2.3*, respectively), whereas the decrease in *ubp12-2* leaf size (32%) resulted from a reduction in cell area (21%) and cell number (11%) ([Figure 2C](#fig2){ref-type="fig"}). Remarkably, besides a general decrease in pavement cell area, we could observe a larger proportion of very small cells in the *UBP12* and *UBP13* overexpression lines ([Figure 2---figure supplement 8](#fig2s8){ref-type="fig"}), which was even more pronounced in homozygous *35S::UBP13_1.1* plants ([Figure 2---figure supplement 9](#fig2s9){ref-type="fig"}). A cell area distribution plot confirmed that indeed all independent *UBP12* and *UBP13* overexpression lines harbored a larger proportion of these small cells in addition to a general decrease in mature pavement cell size ([Figure 2D](#fig2){ref-type="fig"}). For the *ubp12-2* mutant, no differences in cell area distribution compared to Col-0 could be observed ([Figure 2---figure supplement 10](#fig2s10){ref-type="fig"}).

Overexpression of *UBP12* or *UBP13* delays the onset of endoreduplication and cell differentiation in leaves {#s2-3}
-------------------------------------------------------------------------------------------------------------

A strong reduction in cell size is often correlated with decreased levels of endoreduplication. To explore this into more detail, we harvested a time-course of the first leaf pair of Col-0, *35S::UBP12_3.1* and *35S::UBP13_1.1* (hereafter referred to as *35S::UBP12* and *35S::UBP13*) plants, spanning all major developmental time points. At nine days after stratification (DAS), all leaf cells of the three lines exhibited a 2C or 4C content, demonstrating the majority of cells are still in the mitotic cell cycle ([Figure 3A](#fig3){ref-type="fig"}). From 12 DAS onwards, cells with 8C started to appear, indicating the onset of endoreduplication. At 12 DAS, leaves of *35S::UBP12* plants contained a significantly larger proportion of 2 C cells (53%) than those of the Col-0 (43%) and a significantly lower amount of 4 C cells (44% and 52%, respectively). At 15 DAS, the amount of 8C nuclei was significantly lower in *35S::UBP12* (28%) than in the control (35%) ([Figure 3A](#fig3){ref-type="fig"}). Similar, but more pronounced observations were found in *35S::UBP13* leaves, in which a significantly higher amount of 2 C cells was detected at 12 DAS (61%) and 15 DAS (42%) compared to Col-0 (43% and 25%, respectively). In addition, a lower level of 4 C cells was found at 12 DAS (35% in *35S::UBP13*, 52% in Col-0) and fewer cells with 8C were present at 15, 18, 21 and 27 DAS in *35S::UBP13* (22%, 33%, 35% and 35%, respectively) compared to Col-0 (35%, 42%, 42% and 46%, respectively) ([Figure 3A](#fig3){ref-type="fig"}). An alternative way to illustrate endoreduplication levels is the endoreduplication index, representing the average amount of endocycles a nucleus underwent. Generally, slightly lower endoreduplication levels could be observed in *35S::UBP12* leaves ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), whereas a stronger effect was clear in *35S::UBP13* leaves, with significant differences at 12, 15 and 21 DAS ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).

![UBP12 and UBP13 regulate the onset of endoreduplication.\
(**A**) Ploidy distribution of nuclear DNA in Col-0, *35S::UBP12_3.1* and *35S::UBP13_1.1*. (**B--C**) Fractional difference in expression of cell proliferation markers in *35S::UBP12_3.1* and *35S::UBP13_1.1* compared to Col-0 at (**B**) nine and (**C**) 12 DAS. (**D**) Representations of abaxial leaf epidermal cells at the tip of the third leaf of Col-0, *35S::UBP12_3.1* and *35S::UBP13_1.1* at 12 DAS. Bars represent the SEM, n = 3 biological repeats with \>3 leaves per repeat; a, b and c indicate a significant difference in 2C, 4C and 8C, respectively; \* indicates p-value\<0.05, ANOVA, ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}).\
Figure 3---source data 1.Flow cytometry counts and statistics; Q-RT-PCR data and statistics of proliferation markers in developing leaves (9 DAS and 12 DAS).\
Figure 3---source data 2.Endoreduplication index calculations and statistics; Q-RT-PCR data and statistics of proliferation markers in developing leaves (15 DAS and 18 DAS).](elife-52276-fig3){#fig3}

Because the strongest effects were visible in the younger time points, we subsequently prepared RNA from the younger third leaf until 18 DAS. Considering the higher 2C levels in *35S::UBP12* and *35S::UBP13* ([Figure 3A](#fig3){ref-type="fig"}) and the presence of larger proportions of small cells in the leaf epidermis at 21 DAS ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplements 8](#fig2s8){ref-type="fig"}--[9](#fig2s9){ref-type="fig"}), we measured the expression of several genes that are highly expressed during cell proliferation and whose expression goes down during the transition to differentiation and endoreduplication in leaves: *ANGUSTIFOLIA3* (*AN3*) ([@bib16]), *AINTEGUMENTA* (*ANT*), ([@bib27]), *GROWTH-REGULATING FACTOR 5* (*GRF5*) ([@bib16]; [@bib45]), *KLUH* ([@bib2]) and the cell division marker *CYCLINB1;1* (*CYCB1;1*) ([@bib11]; [@bib36]). At 9 DAS, when all epidermal cells are actively dividing ([@bib3]), we could observe a significantly higher expression of *ANT*, *GRF5* and *KLUH* in *35S::UBP13* lines compared to the Col-0 ([Figure 3B](#fig3){ref-type="fig"}). Later in development at 12 DAS, a large portion of the Col-0 cells should have exited the mitotic division cycle and start to differentiate ([@bib3]; [@bib13]; [@bib21]). Still, there was a significant higher expression of *AN3* and *GRF5* and the cell division marker *CYCB1;1* in *35S::UBP13* leaves ([Figure 3C](#fig3){ref-type="fig"}). On 15 DAS, the expression levels of *ANT* and *CYCB1;one* were elevated in *35S::UBP13* leaves ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}) and finally, at 18 DAS, *ANT* was still significantly higher expressed in *35S::UBP13* compared to the Col-0 ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). To further explore these observations, we characterized the epidermal cells of tips of the third leaf of 12 day old seedlings, which should be undergoing cell differentiation at this stage in Col-0 ([@bib3]). In Col-0 leaf tips, we could indeed observe that the epidermal cells had started to expand and differentiate ([Figure 3D](#fig3){ref-type="fig"}). On the contrary, similar leaf tips of *35S::UBP12* or *35S::UBP13* plants contained almost exclusively undifferentiated cells ([Figure 3D](#fig3){ref-type="fig"}). These results, together with our observation that cell number was not significantly altered in *UBP12* an *UBP13* overexpression lines, indicate that especially during the early developmental stages of leaf growth, endoreduplication and cell differentiation are delayed in *35S::UBP12* and *35S::UBP13* leaves.

UBP12 and UBP13 can deubiquitinate activated DA1, DAR1 and DAR2 {#s2-4}
---------------------------------------------------------------

The latent peptidases DA1, DAR1 and DAR2 can be activated upon ubiquitination by the E3 ligases BB or DA2. Considering the enzymatic function of UBP12 and UBP13, they might counteract this by deubiquitinating these activated peptidases. To test this, we performed an in vitro ubiquitination assay to generate ubiquitinated DA1, DAR1 an DAR2, followed by a deubiquitination step with UBP12 or UBP13, or their respective catalytic mutants, UBP12^C208S^ and UBP13^C207S^ ([@bib9]; [@bib15]). DA1, DAR1 and DAR2 were expressed and isolated as HIS-MBP fusion proteins and UBP12, UBP13, UBP12^C208S^ and UBP13^C207S^ as GST fusion proteins. To mediate the ubiquitination, recombinant HIS-DA2 was purified as the E3 ligase. The ubiquitinated peptidases were incubated with equal amounts of either GST-UBP12, GST-UBP12^C208S^, GST-UBP13 or GST-UBP13^C207S^. [Figure 4A](#fig4){ref-type="fig"} shows that ubiquitinated HIS-MBP-DA1 can be deubiquitinated by GST-UBP12 or GST-UBP13, but their respective catalytic mutants fail to do so. Similar deubiquitination activities could be observed for the substrates DAR1 and DAR2 ([Figure 4B--C](#fig4){ref-type="fig"}). Because the peptidase activity of DA1, DAR1 and DAR2 is similarly activated upon ubiquitination and they function redundantly to regulate leaf size and ploidy, we chose to focus on DA1 in our next experiments.

![In vitro deubiquitination specificity of DA1, DAR1 and DAR2 by UBP12 and UBP13.\
(**A--C**) In vitro deubiquitination assays with GST-UBP12, GST-UBP12^C208S^, GST-UBP13 or GST-UBP13^C207S^ of (**A**) HIS-MBP-DA1, (**B**) HIS-MBP-DAR1 and (**C**) HIS-MBP-DAR2. (**D**) Deubiquitination assay with GST-UBP12, GST-UBP13, GST-UBP3, GST-UBP15 and GST-UBP24 of HIS-MBP-DA1.](elife-52276-fig4){#fig4}

To demonstrate the specificity of UBP12 and UBP13, we performed additional deubiquitination experiments with several UBPs from different subfamilies ([@bib49]): GST-UBP3, GST-UBP24 and GST-UBP15, of which the latter had already been demonstrated to function in the same pathway of DA1 ([@bib14]) as its cleavage substrate ([@bib12]). Ubiquitinated HIS-MBP-DA1 was incubated with equal amounts of GST-UBP12, GST-UBP13, GST-UBP3, GST-UBP15 and GST-UBP24. We found again that both GST-UBP12 and GST-UBP13 could strongly deubiquitinate HIS-MBP-DA1, but no such effect could be observed upon addition of GST-UBP3, GST-UBP15 or GST-UBP24 ([Figure 4D](#fig4){ref-type="fig"}).

To further consolidate these observations, we evaluated the effect of different in vivo levels of UBP12 and UBP13 on the ubiquitination status of DA1. To realize this, we produced ubiquitinated DA1 in vitro and incubated it with equal amounts of cell-free extracts of Col-0 and *ubp12-2* seedlings, the latter containing lower protein levels of UBP12 and UBP13. Already after 1 hr, we could observe a shift in molecular weight in the ubiquitinated HIS-MBP-DA1 samples that were incubated with Col-0 extract ([Figure 5A](#fig5){ref-type="fig"}), and this shift did not occur in the sample that was incubated with the *ubp12-2* extract ([Figure 5B](#fig5){ref-type="fig"}). In addition, the intensity of ubiquitinated HIS-MBP-DA1 bands faded faster in the presence of Col-0 extract than in the presence of *ubp12-2* extract ([Figure 5A--C](#fig5){ref-type="fig"}). We performed a similar experiment with extracts of *35S::UBP12* and *35S::UBP13* plants, which contain higher levels of UBP12 or UBP13 proteins respectively. First, we could confirm the faster loss in molecular weight and intensity of ubiquitinated HIS-MBP-DA1 in Col-0 ([Figure 5D](#fig5){ref-type="fig"}) than in *ubp12-2* after 2 hr and 4 hr of incubation ([Figure 5E](#fig5){ref-type="fig"}). In addition, when ubiquitinated DA1 proteins were incubated with equal extracts of *35S::UBP12* ([Figure 5F](#fig5){ref-type="fig"}) or *35S::UBP13* ([Figure 5G](#fig5){ref-type="fig"}) plants, the intensity of ubiquitinated HIS-MBP-DA1 disappeared at a faster rate ([Figure 5D--H](#fig5){ref-type="fig"}). At 6 hr or 8 hr of incubation, no HIS-MBP-DA1 bands could be distinguished anymore from the background, these results could therefore not be interpreted ([Figure 5D--H](#fig5){ref-type="fig"}). In addition, we extracted proteins of *35S::GFP-DA1*, *35S::GFP-DA1_35S::UBP12* and *35S::GFP-DA1_35S::UBP13* plants and performed a purification with anti-GFP beads from equal protein inputs. After purification, we submitted the samples to Western Blot and detected the abundance of GFP-DA1 proteins. We could not identify increases in protein abundance in the *35S::GFP-DA1_35S::UBP12* and *35S::GFP-DA1_35S::UBP13* samples compared to those of *35S::GFP-DA1* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), suggesting UBP12 and UBP13 do not prevent potential removal of polyubiquitination of DA1 and hereby prevent its degradation by the proteasome.

![Deubiquitination of DA1, DAR1 and DAR2 by UBP12 and UBP13 in vivo.\
(**A--B**) Cell-free deubiquitination assay of ubiquitinated HIS-MBP-DA1 proteins incubated with (**A**) Col-0 or (**B**) *ubp12-2* extract. (**C**) Quantification of deubiquitination ([Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). (**D--G**) Cell-free deubiquitination assay of ubiquitinated HIS-MBP-DA1 with (**D**) Col-0, (**E**) *ubp12-2*, (**F**) *35S::UBP12* or (**G**) *35S::UBP13* extracts. (**H**) Quantification of deubiquitination ([Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}).\
Figure 5---source data 1.Calculation of in vivo deubiquitination.](elife-52276-fig5){#fig5}

These experiments demonstrate the deubiquitination specificity by UBP12 and UBP13 in vitro and the positive effects of high in vivo UBP12 or UBP13 protein levels on the deubiquitination of DA1. In addition, high levels of UBP12 or UBP13 do not seem to affect the stability of DA1 in vivo.

UBP12 and UBP13 are not substrates of the activated DA1 {#s2-5}
-------------------------------------------------------

Our observation that UBP12 and UBP13 can deubiquitinate DA1, DAR1 and DAR2 suggests they work upstream in this growth-regulatory pathway. Considering the peptidase activity of DA1, DAR1 and DAR2, we tested whether these deubiquitinating enzymes could in their turn be substrates. For this purpose, we incubated GST-UBP12, GST-UBP12^C208S^, GST-UBP13 and GST-UBP13^C207S^ with ubiquitinated HIS-MBP-DA1 or the peptidase-deficient HIS-MBP-DA1^H418A,H422A^ ([@bib12]). The catalytic UBP mutants were added to the assay because they are unable to deubiquitinate DA1 ([Figure 4A](#fig4){ref-type="fig"}) and, hence, are exposed for a longer time to the activated peptidase. However, after 4 hr of incubation, the intensities of all GST-tagged UBP proteins were equal and no additional cleaving fragments could be observed in the HIS-MBP-DA1 samples compared to those with HIS-MBP-DA1^H418A,H422A^ ([Figure 6A](#fig6){ref-type="fig"}). Similar results were observed in the reactions in which the catalytic mutants of UBP12 or UBP13 were incubated with ubiquitinated HIS-MBP-DA1 or HIS-MBP-DA1^H418A,H422A^ ([Figure 6A](#fig6){ref-type="fig"}).

![Cleaving assay on UBP12 and UBP13.\
(**A**) In vitro cleaving assay on GST-UBP12, GST-UBP12^C208S^, GST-UBP13 and GST-UBP13^C207S^ by HIS-MBP-DA1 and the peptidase-deficient HIS-MBP-DA1^H418A,H422A^. (**B**) Twenty-one-day-old plants of Col-0, *35S::GFP-DA1*, *35S::UBP12_3.1/35S::GFP-DA1*, *35S::UBP12_3.2/35S::GFP-DA1*, *35S::UBP13_2.1/35S::GFP-DA1* and *35S::UBP13_2.2/35S::GFP-DA1* homozygous (+/+) and heterozygous (+/-) double overexpression lines. Scale bar represents 1 cm.\
Figure 6---source data 1.Q-RT-PCR data and statistics of *DA1*, *UBP12* and *UBP13* expression in Col-0, *35S::GFP-DA1*, *35S::UBP12_3.1/35S::GFP-DA1*, *35S::UBP12_3.2/35S::GFP-DA1*, *35S::UBP13_2.1/35S::GFP-DA1* and *35S::UBP13_2.2/35S::GFP-DA1.*](elife-52276-fig6){#fig6}

Previously, it has been demonstrated that the dwarfed phenotype of strong *BB* overexpression lines could largely be rescued by ectopic co-expression of *DA1*, as a result of the cleavage and destabilization of BB proteins ([@bib12]). Similarly, we generated double overexpression lines of *35S::GFP-DA1* and *35S::UBP12* or *35S::UBP13* ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Compared to Col-0, leaf areas were reduced in *35S::GFP-DA1* ([Figure 6B](#fig6){ref-type="fig"}), as described before ([@bib44]). In all double overexpression lines, we could observe similar phenotypes as in the *35S::UBP12* and *35S::UBP13* lines in the Col-0 background ([Figure 6B](#fig6){ref-type="fig"}, [Figure 2A](#fig2){ref-type="fig"}), suggesting that the *UBP12* and *UBP13* overexpression phenotype is dominant and UBP12 and UBP13 are not destabilized by DA1.

Thus, our biochemical, genetic and phenotypic analyses show that UBP12 and UBP13 are not cleavage substrates, but act upstream of DA1, DAR1 and DAR2 to counteract their ubiquitination. By limiting their peptidase activity, UBP12 and UBP13 fine-tune leaf growth, cell size and endoreduplication.

Discussion {#s3}
==========

Ubiquitination is an important post-transcriptional modification that comes in various forms of complexity, which can lead to diverse effects on the fate of the substrate protein ([@bib6]; [@bib39]). The latent peptidases DA1, DAR1 and DAR2 are activated upon multiple mono-ubiquitinations by BB and DA2 and can subsequently cleave several growth regulators ([@bib12]). In this study, we identified two ubiquitin-specific proteases, UBP12 an UBP13, that interact with DA1, DAR1 and DAR2 in vitro and in vivo. Our experiments demonstrate that these UBPs work antagonistically to BB and DA2. Incubation of ubiquitinated DA1, DAR1 or DAR2 with either UBP12 or UBP13 resulted in strong deubiquitination. Interestingly, our in vitro immunoprecipitation (IP) shows that UBP12 and UBP13 can also interact with the unubiquitinated forms of DA1, DAR1 and DAR2. Similar deubiquitination experiments with other UBPs, such as UBP3, UBP15 and UBP24, demonstrated that this activity was specific for UBP12 and UBP13. Interestingly, *UBP15* has already been shown to genetically interact with *DA1* ([@bib14]) and UBP15 proteins can be cleaved by activated DA1 peptidases ([@bib12]). Our results indicate that UBP15 has no deubiquitination activity towards DA1 and acts therefore downstream in this pathway. On the other hand, UBP12 and UBP13 are not substrates of DA1, unlike UBP15 ([@bib12]; [@bib14]), which suggests they work more upstream in this signaling cascade. Most probably, UBP15 deubiquitinates and alters the fate of other downstream growth-regulating proteins. UBP12 and UBP13 have recently been described to deubiquitinate various poly-ubiquitinated proteins, preventing their proteasomal degradation ([@bib1]; [@bib19]; [@bib23]; [@bib30]). In addition, they can decrease the levels of mono-ubiquitinated H2A ([@bib10]) and remove multiple mono-ubiquitinations from DA1, DAR1 and DAR2 as described here. This demonstrates the flexibility of these UBPs towards different types of ubiquitination ([@bib7]). Here, we could not find evidence that besides the removal of the multiple mono-ubiquitination sites of DA1, DAR1 and DAR2, potential degradation of these proteins by removal of poly-ubiquitination was mediated by UBP12 or UBP13.

In contrast to the early flowering time-related genes ([@bib9]), downregulation of either *UBP12* or *UBP13* did not alter leaf size, indicating that these genes work redundantly in controlling leaf size. The leaf area was only reduced in *ubp12-2* mutants, in which levels of both *UBP12* and *UBP13* are decreased ([@bib9]). The subsequently decreased deubiquitination activity towards DA1, DAR1 and DAR2 could result in an accumulation of the activated peptidases in *ubp12-2* mutants, leading to a decrease in cell number and leaf area. A similar phenotype is also observed in *GFP-DA1* overexpressing plants ([@bib44]) and in the *ubp15* mutant ([@bib14]; [@bib25]). In contrast, high ectopic expression of either *UBP12* or *UBP13* would result in very low levels of ubiquitinated DA1, DAR1 and DAR2, leading to a severe disturbance of leaf development. Indeed, *35S::UBP12* and *35S::UBP13* plants were strongly reduced in growth in a similar manner as *da1ko_dar1-1_dar2-1* triple mutants ([@bib31]). A more detailed cellular and molecular analysis of *35S::UBP12* and *35S::UBP13* leaves revealed more parallels, such as a strong reduction in cell area and a decrease in ploidy levels at the early stages of leaf development, which were also observed in *da1ko_dar1-1_dar2-1* plants ([@bib31]). The complete absence of DA1, DAR1 and DAR2 proteins in *da1ko_dar1-1_dar2-1* plants could however explain its stronger reduction in endoreduplication than that of *UBP12* and *UBP13* overexpression lines, in which ubiquitination of DA1, DAR1 and DAR2 can still occur, but is likely kept at a very low level. In addition, several markers of cell proliferation were found to be more highly expressed in *35S::UBP12* and *35S::UBP13* during early stages of leaf development, similarly as observed in plants that contain a DA1^R358K^ mutation ([@bib44]), which reduces the peptidase activity of DA1 ([@bib12]). However, the final cell number in the *UBP12* and *UBP13* overexpression lines was not increased, suggesting that a strong reduction of DA1 activity rather delays development but does not increase the duration of cell proliferation and hence the final number of cells.

Previously, it has been shown that DA1, DAR1 and DAR2 negatively regulate their own activity by cleaving their activating E3-ligases BB and DA2, resulting in an activation-repression system ([@bib12]). UBP12 and UBP13 form an additional layer of post-translational regulation to limit the activity of DA1, DAR1 and DAR2 by specifically removing ubiquitin, and hence further fine-tune organ growth in this growth-regulatory pathway. This dual system to limit and fine-tune the activity of DA1, DAR1 and DAR2 demonstrates the importance of keeping a correct balance between the active and inactive pool of these proteases during leaf development. This is illustrated by the phenotype of plants in which this balance is altered. In wild-type conditions, a correct balance between an inactive and active (ubiquitinated) DA1, DAR1 and DAR2 results in an intact exit from mitosis and standard ploidy levels in leaf cells, which leads to normal plant growth ([Figure 7A](#fig7){ref-type="fig"}). High levels of UBP12 or UBP13 can however shift the balance to a depletion of activated DA1, DAR1 and DAR2, which results in a delayed endoreduplication, a severe reduction in cell size and stunted plant growth ([Figure 7B](#fig7){ref-type="fig"}), which is highly similar to the phenotype of *da1ko_dar1-1_dar2-1* mutants ([@bib31]). Low levels of UBP12 and UBP13 might on the other hand lead to an increase in activated DA1, DAR1 and DAR2 levels, more destabilization of its substrates and can hence limit plant growth by reducing both cell area and cell number ([Figure 7C](#fig7){ref-type="fig"}). Higher levels of DA1 and mutations in *UBP15* have previously been reported to decrease leaf area and cell number ([@bib14]; [@bib25]; [@bib44]). In *ubp12-2* mutants and overexpression lines of *UBP12* and *UBP13*, leaf size and the average area of pavement cells are reduced. Because both very low and high levels of DA1 result in growth reduction ([@bib31]; [@bib44]), a tight balance between active and inactive DA1, DAR1 and DAR2 is crucial for normal plant development. With *UBP12* and *UBP13* expression levels being relatively constant throughout leaf development, unknown post-translational modifications of UBP12 and UBP13 are likely to alter the activity or specificity towards DA1, DAR1 and DAR2, as is the case with other deubiquitinating enzymes ([@bib17]). Additionally, it remains also unclear if this reduction in cell area in the *ubp12-2* mutants or *UBP12* and *UBP13* overexpression lines results only from altered levels of DA1 activity, or if UBP12 and UBP13 regulate cell expansion through other growth regulators.

![Model of UBP12 and UBP13 levels on leaf area and cellular phenotypes.\
Molecular balance and leaf phenotypes in (**A**) wild-type conditions, (**B**) high *UBP12* and *UBP13* expression lines and (**C**) lower levels of *UBP12* and *UBP13*.](elife-52276-fig7){#fig7}

Over the years, it has become increasingly clear that DUBs play a greater role in the development of eukaryotes than just processing and recycling free ubiquitin. Many DUBs are involved in fine-tuning molecular pathways by stabilizing proteins ([@bib1]; [@bib19]; [@bib23]; [@bib30]), through controlling protein endocytosis ([@bib8]; [@bib33]), by mediating DNA damage repair ([@bib29]) and by regulating transcription ([@bib10]; [@bib20]; [@bib51]) to name a few. Potentially, DUBs could remove ubiquitin of existing chains so other chain types can be formed or other PTMs can be added.

Although our knowledge of organ growth has increased substantially over the last years ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), the developmental and environmental triggers that initiate the ubiquitination and deubiquitination of DA1, DAR1 and DAR2, the dominant-negative nature of DA1^R358K^, additional potential substrates of the ubiquitin-activated peptidases and other post-translational regulatory elements remain some of the many compelling mysteries of this intriguing growth-regulatory pathway.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                   Designation          Source or reference   Identifiers                 Additional\
  (species) or resource                                                                                  information
  ------------------------------- -------------------- --------------------- --------------------------- ---------------------------------------------------------------------------
  Gene (*Arabidopsis thaliana*)   DA1                  TAIR                  AT1G19270                   

  Gene (*Arabidopsis thaliana*)   DAR1                 TAIR                  AT4G36860                   

  Gene (*Arabidopsis thaliana*)   DAR2                 TAIR                  AT2G39830                   

  Gene\                           UBP12                TAIR                  AT5G06600                   
  (*Arabidopsis thaliana*)                                                                               

  Gene (*Arabidopsis thaliana*)   UBP13                TAIR                  AT3G11910                   

  Gene (*Arabidopsis thaliana*)   UBP3                 TAIR                  AT4G39910                   

  Gene\                           UBP15                TAIR                  AT1G17110                   
  (*Arabidopsis thaliana*)                                                                               

  Gene\                           UBP24                TAIR                  AT4G30890                   
  (*Arabidopsis thaliana*)                                                                               

  Gene\                           DA2                  TAIR                  AT1G78420                   
  (*Arabidopsis thaliana*)                                                                               

  Cell line\                      *Landsberg erecta*   TAIR/ABRC             Germplasm:6530492727\       <https://www.arabidopsis.org/servlet/TairObject?id=4502009498&type=stock>
  (*Arabidopsis thaliana*)                                                   NASC stock number: N84840   

  Strain, strain\                 DH5 α                Thermo-fisher         18258012                    Chemically\
  background\                                                                                            competent cells
  (*Escherichia coli*)                                                                                   

  Strain, strain\                 BL21(DE3)            Thermo-fisher         EC0114                      Chemically competent cells
  background\                                                                                            
  (*Escherichia coli*)                                                                                   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plant material and growth conditions {#s4-1}
------------------------------------

All *Arabidopsis thaliana* mutants and overexpression lines that were used in this study were from the Col-0 background. *ubp12-1* (GABI_244E11), *ubp12-2* (GABI_742C10), *ubp13-1* (SALK_128312), *ubp13-2* (SALK_024054) and *ubp13-3* (SALK_132368) were kindly provided by Dr. Xia Cui (Chinese Academy of Agricultural Sciences, Beijing, China). The respective T-DNA insertions were verified by PCR. The *35S::GFP-DA1*, *35S::GFP-DAR1* and *35S::GFP-DAR2* lines were generated by Gateway cloning using the pK7WGF2 destination vector, the *35S::UBP12* and *35S::UBP13* lines using the pFAST-G02. Because the latter overexpression lines contained the *OLE1::GFP* construct ([@bib37]), we could select positive seeds using a fluorescence binocular. The T-DNA lines were grown in soil for 25 days at 21°C and 16-h day/8-hr night cycles for the phenotyping experiments. All overexpression lines and the *da1-1* mutant were grown in vitro on plates containing half-strength Murashige and Skoog (MS) medium supplemented with 1% sucrose with a density of one plant per 4 cm^2^. These plants were grown for 21 days at 21°C and 16-h day/8-hr night cycles. Seedlings for the immunoprecipitation followed by tandem mass spectrometry (IP-MS/MS) were grown for 8 days in liquid half-strength MS medium supplemented with 1% sucrose under shaking conditions (100 rpm) at 21°C and 16-h day/8-hr night cycles. For all experiments, the seeds were stratified in the dark for 2 days at 4°C before being placed in the respective growth rooms. Each quantitative experiment was performed in at least three independent biological repeats, meaning they were sown and harvested at a different time. All genotyping and cloning primers that were used in this study are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Leaf measurements and cellular analysis {#s4-2}
---------------------------------------

Leaves were dissected from the rosette and placed on a square plate containing 1% agar. The plants were imaged and the leaf area was analyzed using ImageJ v1.45 ((RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070), NIH; <http://rsb.info.nih.gov/ij/>). For the cellular analysis, samples of leaf 3 (overexpression lines) and leaf 5 (*ubp12-2*) were cleared in 70% ethanol and mounted in lactic acid on a microscope slide. The total leaf blade area was measured for at least ten representative leaves under a dark-field binocular microscope. For mature leaves, abaxial epidermal cells at the center of the leaf blade, avoiding major veins, were drawn with a microscope equipped with differential interference contrast optics (DM LB with 403 and 633 objectives; Leica) and a drawing tube for at least three leaves. Photographs of leaves and scanned cell drawings were used to measure leaf and individual cell area, respectively, as described by [@bib3]. The statistical analysis of the cellular data was performed in R 3.5.2 ([www.r-project.org](http://www.r-project.org), RRID:[SCR_001905](https://scicrunch.org/resolver/SCR_001905)). For the cellular profiling during the transition of cell proliferation to cell expansion, abaxial cells were drawn at the tip of the third leaf at 12 DAS. Scans of cellular drawings were analyzed using ImageJ v1.45 (RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070), NIH; <http://rsb.info.nih.gov/ij/>) and cells were colored according to their area in Inkscape (<https://inkscape.org/>, RRID:[SCR_014479](https://scicrunch.org/resolver/SCR_014479)).

In vitro deubiquitination and cleaving assays {#s4-3}
---------------------------------------------

The coding sequences of *UBP3*, *UBP12*, *UBP13*, *UBP15* and *UBP24* were inserted in the pDEST15 (Thermo Fisher, RRID:[SCR_008452](https://scicrunch.org/resolver/SCR_008452)) destination vector using Gateway cloning to generate GST-UBP3, GST-UBP12, GST- GST-UBP13, GST-UBP15 and GST-UBP24. The coding sequences of *DA1*, *DAR1* and *DAR2* were cloned into pDEST-HIS-MBP using Gateway cloning to generate HIS-MBP-DA1, HIS-MBP-DAR1 and HIS-MBP-DAR2. The HIS-DA2 (pET24a) construct was kindly provided by Prof. Michael Bevan (JIC, Norwich, UK). To generate the respective catalytic mutants, we performed site-directed mutagenesis on the entry clones of the respective genes by performing a PCR with primers containing the mutation. After the PCR, 5 µl of Buffer B and 1 µl of DpnI (Promega, RRID:[SCR_006724](https://scicrunch.org/resolver/SCR_006724)) were added to each reaction. After an overnight incubation, competent DH5α *E. coli* cells were transformed and the presence of the mutation was checked by sequencing. All expression vectors were transformed into competent BL21 (DE3) *E. coli* cells. For each protein, the optimal conditions to obtain sufficient soluble proteins were determined ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). GST-tagged proteins were purified from the bacterial lysate with Glutathione Sepharose 4B beads (GE Healthcare, 17075601) and HIS-tagged proteins with NI-NTA agarose beads (QIAGEN, 30210). Purified proteins were loaded on 4--15% Mini-PROTEAN TGX Precast Protein Gels (Biorad, 4561083DC), stained overnight with Instant Blue (Sigma-Aldrich, ISB1L-1L) and quantified using a BSA standard curve in Image Lab (RRID:[SCR_014210](https://scicrunch.org/resolver/SCR_014210), Biorad). The ubiquitination of DA1, DAR1 and DAR2 and the cleaving assays were performed as described before ([@bib12]). After the ubiquitination step, a 1:1 ratio of deubiquitinating enzymes to the ubiquitinated proteins were added and the reaction mix was incubated for 4 hr at 30°C. Reactions were stopped by adding 5x SDS sample buffer and boiled for ten min at 90°C. The samples were loaded on 4--15% or 7.5% Mini-PROTEAN TGX Precast Protein Gels (Biorad, 4561083DC). The proteins in the gels were transferred to a PVDF membrane using Trans-blot turbo transfer packs (Biorad, 170--4156) and the membranes were incubated overnight in a 3% skimmed milk (Difco) 1x TBST solution. After blocking, GST-tagged proteins were detected with Anti-GST HRP Conjugate (Sigma-Aldrich, GERPN1236, RRID:[AB_2827942](https://scicrunch.org/resolver/AB_2827942)) and MBP-tagged proteins with Anti-MBP Monoclonal Antibody (NEB, E8030S, RRID:[AB_1559728](https://scicrunch.org/resolver/AB_1559728)) and subsequently with a secondary Rabbit IgG HRP Linked antibody (Sigma-Aldrich Cat\# GENA934, RRID:[AB_2722659](https://scicrunch.org/resolver/AB_2722659)). The antibodies were used following the manufacturer's instructions.

RNA extraction, cDNA preparation and q-RT-PCR {#s4-4}
---------------------------------------------

Total RNA was extracted from flash-frozen seedlings or isolated leaves with TRIzol reagent (Invitrogen). Young seedlings (until 14 DAS) from which the leaves were isolated using a binocular were submerged overnight in RNA Later (Ambion) to prevent RNA degradation. To eliminate the residual genomic DNA present in the preparation, the RNA was treated by RQ1 RNAse-free DNase according to the manufacturer\'s instructions (Promega) and purified with the RNeasy Mini kit (Qiagen). Complementary DNA was made with the QScript cDNA supermix kit (Quantabio, 95048--100) according to the manufacturer\'s instructions. Q-RT-PCR was done on a LightCycler 480 (Roche) in 384-well plates with LightCycler 480 SYBR Green I Master mix (Roche) according to the manufacturer\'s instructions. Primers were designed with the Primer3 (RRID:[SCR_003139](https://scicrunch.org/resolver/SCR_003139), <http://frodo.wi.mit.edu/>) ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Data analysis was performed using the ΔΔCT method ([@bib32]), taking the primer efficiency into account. The expression data was normalized using three reference genes (AT1G13320, AT2G32170, and AT2G28390) according to the GeNorm algorithm ([@bib43]). The statistical analysis (ANOVA, Dunnett's test) was performed in GraphPad Prism 8.1 ([www.graphpad.com](http://www.graphpad.com), RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)).

Flow cytometry {#s4-5}
--------------

The first leaf pair was harvested from 9 to 27 DAS with a three-day interval and frozen in liquid nitrogen. At least three leaves per time point of each biological repeat (n = 3) were chopped with a razor blade in 200 µL of Cystain UV Precise P Nuclei Extraction buffer (Sysmex), followed by the addition of 800 µL of Cystain UV Precise P staining buffer (Sysmex) and filtering through a 50-mm filter. Nuclei were analyzed with the Cyflow MB flow cytometer (Partec) and the FloMax software (RRID:[SCR_014437](https://scicrunch.org/resolver/SCR_014437)). The statistical analysis (ANOVA, Dunnett's test) was performed in GraphPad Prism 8.1 ([www.graphpad.com](http://www.graphpad.com), RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)).

IP-MS/MS {#s4-6}
--------

The IP-MS/MS was based on the protocol from [@bib48]. For each pull-down, we used 3 g of homogenized Arabidopsis seedlings. The powder was dissolved in 4.5 ml BHB+ buffer supplemented with 4.5 µl benzonase and incubated for 30 min at 4°C. Then, the samples were further mixed three times for 30 s at 18,000 rpm using Ultra-TURRAX miniprobes (IKA). Subsequently, the mixtures were incubated for 30 min at 4°C on an end-over-end rotor. After incubation, the cellular debris was pelleted by two centrifugation steps at 14,000 rpm at 4°C in an Eppendorf centrifuge and further withheld by a 0.45-μm filter (Sartorius). The protein content was measured (OD 595) using a Bradford (Biorad) standard curve and equal amounts of proteins were incubated with 50 μl pre-washed anti-GFP-beads (μMacs, Miltenyi Biotec, RRID:[AB_2827943](https://scicrunch.org/resolver/AB_2827943)) for 1 hr at 4°C in an end-over-end shaker. To isolate the beads, the columns were placed in the magnetic holder and washed four times with 200 μl BHB+ buffer and two times with 500 μl NH~4~HCO~3~ buffer. The purified proteins were eluted stepwise by 50 μl 95°C hot NH~4~HCO~3~ each time until no more beads pass through the column. Then, 4 μl Tryp/LysC mix (Promega) was added and the proteins were digested on-bead for 4 hr at 37°C with agitation (800 rpm) on an Eppendorf thermomixer. The digested mix was loaded again on the μMacs column attached to the magnetic holder to separate the eluate from beads. The eluate was collected in a new protein low binding Eppendorf tube and additionally 2 μl Tryp/LysC was added for an overnight digestion at 37°C with agitation (800 rpm) in an Eppendorf thermomixer. Finally, the samples were snap-frozen in liquid nitrogen and freeze-dried in a Speedvac (Labconco). Protein identification and data analysis were performed as described before ([@bib42]).

In vitro and in vivo pull-own {#s4-7}
-----------------------------

The in vitro pull-down experiments were performed as described before ([@bib12]). As recombinant bait proteins, we used equal quantities of recombinant GST (Prospec, ENZ-393) and full-length GST-UBP12 or GST-UBP13. For the in vivo pull-down, full expression constructs of *35S::RFP-DA1*, *35S::RFP-DAR1*, *35S::RFP-DAR2*, *35S::GFP-UBP12* and *35S::GFP* were amplified by PCR and cloned into Golden Gate modules (pGGA000, pGGB000) using the Gibson assembly method (NEB, E5510S). Existing *bsaI* sites in the Gateway p35S and DAR1 coding sequence were mutated by site-directed mutagenesis using *DpnI*. Subsequently, these constructs were cloned as interaction pairs on a Golden Gate vector to ensure the co-expression of the constructs in each cell. Arabidopsis cell suspension cultures were transformed as described before ([@bib41]). Proteins were extracted and purified as described above and the purified fraction was subjected to Western blot. After blocking, GFP-tagged proteins were detected with anti-GFP (Abcam, ab290, RRID:[AB_303395](https://scicrunch.org/resolver/AB_303395)) and RFP-tagged proteins with anti-RFP antibody (Chromotek, RFP antibody \[6G6\], RRID:[AB_2631395](https://scicrunch.org/resolver/AB_2631395)) and subsequently with a secondary Rabbit IgG HRP-linked antibody (Sigma-Aldrich, NA934v, RRID:[AB_2722659](https://scicrunch.org/resolver/AB_2722659)) or secondary Mouse IgG HRP-linked antibody (Sigma-Aldrich, NA931v, RRID:[AB_2827944](https://scicrunch.org/resolver/AB_2827944)), respectively.

Cell free deubiquitination assay {#s4-8}
--------------------------------

Proteins were freshly extracted from 8-day-old seedlings of Col-0, *ubp12-2*, *35S::UBP12* an *35S::UBP13* using a 0.5 M sucrose, 1 mM MgCl2, 10 mM EDTA (pH 8.0), 5 mM DTT, 50 mM Tris-MES (pH 8.0) extraction buffer without protease inhibitors (one µl of buffer was added per mg plant material). Subsequently, 400 µg of cell-free extract was added per 200 ng ubiquitinated HIS-MBP-DA1 proteins. For each time point, equal amounts of reaction mix were taken and the reaction was stopped by the addition of SDS sample buffer. The samples were blotted and detected as described above. To quantify the deubiquitination, a rectangle was drawn in ImageJ (RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070), NIH; <http://rsb.info.nih.gov/ij/>) spanning the size of fully ubiquitinated HIS-MBP-DA1. Then, the lane intensities were plotted and the pixels within the resulting curves were measured.

Transient expression and confocal microscopy {#s4-9}
--------------------------------------------

For the co-localization experiments, the coding sequences of *DA1*, *DAR1* and *DAR2* were cloned in the gateway destination vector pK7WGR2 and those of *UBP12* and *UBP13* in pK7WGF2 to generate N-terminal RFP- and GFP fusion constructs, respectively. A 3-ml culture of competent LBA 4404 cells containing these constructs or P19 was grown overnight (28°C) in YEB medium with the appropriate antibiotics. The next day, one ml of this culture was inoculated in a 9-ml YEB, 10-mM MES, 20-µM acetosyringone solution with the appropriate antibiotics and incubated overnight at 28°C. Then, the bacteria were washed twice in a 100-mM MGCl2, 10-mM MES, 20-µM acetosyringone buffer and the OD~600~ was adjusted to one for all cultures and further incubated for two hours at 28°C. Then, equal mixtures of the constructs were infiltrated in 4-week-old *Nicotiana benthamiana* leaves. After three nights, leaf discs were imaged with a Zeiss LSM 710 confocal inverted microscope (RRID:[SCR_018063](https://scicrunch.org/resolver/SCR_018063), Zeiss) to image the RFP- (lasers: 561 nm: 3.0%, beam splitters: MBS: MBS 488/561, pinhole: 100 µm,, digital gain: 1.00, Master gain: 925) and GFP fusion proteins (lasers: 488 nm: 2.0%, beam splitters: MBS_InVis: Plate, pinhole: 100 µm, digital gain: 0.75, Master gain: 956).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This work reveals the complex interplay of ubiquitin binding proteins (UBPs) and DA1-related proteins, shedding mechanistic light on ubiqutin-dependent cell identity switches and the control of organ size.

**Decision letter after peer review:**

Thank you for submitting your article \"UBP12 and UBP13 negatively regulate the activity of the ubiquitin-dependent peptidases DA1, DAR1 and DAR2\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Jürgen Kleine-Vehn as the Reviewing Editor and Christian Hardtke as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers appreciated the mechanistic advance of your work, unraveling the regulatory importance of UBPs for the ubiquitin-dependent regulation of DA1, DAR1, and DAR2. However, they request that you should further consolidate your core findings prior publication at *eLife*. Mandatory requests include:

1\) Please, provide a confirmation of the physical interaction of UBPs and DAs through another method.

2\) Please, illustrate the differences in the level of DA1 ubiquitination depending on UBP12 and UBP13 activity.

3\) Please, revise the model at the end so it only reflects what has definitely been shown in this (and previous) studies.

4\) To complement the in vitro evidence, the reviewers kindly ask to possibly test whether overexpression or downregulation of UBP12/3 indeed affect DA1/DAR1/2 peptidase activity and thereby impact cleavage or protein stability of UBP15 and TCPs in protoplasts.

Please, also see the specific comments of the reviewers below, which you may also discuss in your revised manuscript.

Reviewer \#1:

The manuscript by Vanhaeren et al. reports that UBP12/13 deubiquitinate DA1, DAR1 and DAR2, which might reduce their peptidase activity. Overexpression of UBP12 or UBP13 strongly decreased leaf size and cell area, and had lower ploidy levels. Mutations in UBP12 and UBP13 also produced smaller leaves that contained fewer and smaller cells. It seems interesting, but several conclusions are not justified.

1\) If UBP12/13 can deactivate DA1/DAR1/2 (Figure 6), mutations in UBP12/13 could increase the accumulation of TCP15/22 and UBP15, resulting in larger and fewer cells. However, ubp12 *ubp13* mutants produced smaller leaves that contained smaller and fewer cells. In addition, the authors did not confirm whether ubp12 ubp13 could affect the levels of TCP15/22 and UBP15 proteins. Thus, the working model in Figure 6 might be incorrect.

2\) It is unclear whether UBP12/13 can really remove monoubiquited DA1/DAR1/DAR2 or/and polyubiquitated DA1/DAR1/2 in vitro and in vivo. The polyubiquitination might affect protein stability. As the authors generated *35S:UBP12 / 35S:GFP-DA1* and *35S:UBP13 / 35S:GFP-DA1* plants, it is easy to test whether UBP12/13 could affect the stability of DA1 by Western blots.

3\) If UBP12/13 can repress the activity of DA1/DAR1/2, it is necessary to test whether mutations in DA1/DAR1/2 could suppress the phenotypes of ubp12/13.

4\) The authors showed the in vivo interaction of DA1 family proteins with UBP12 and UBP13 by label-free MS analyses. However, it\'s better to provide more interaction evidence by other approaches since MS analyses give false positive results some time.

Reviewer \#2:

This paper by Vanhaeren et al. identifies and characterises a novel role for two deubiquitinating enzymes (UBP13 and 13) in the control of peptidase activity linked to cell growth. It was previously shown that the E3 ligases BB and DA2 monoubiquitinate and activate the latent peptidases DA1, DAR1 and DAR2, which then go on to limit leaf growth through disabling a range of positive regulators. Using a combination of mass-spec based screening, genetic manipulation, phenotypic analysis of growth and cell size, and in vitro biochemistry, the authors of this work identify UBP12 and 13 as interaction partners of the DA1/DAR1/DAR2 peptidases, and show convincingly that they act upstream of peptidase function through specific and selective deubiquitination. Thus, this work identifies a new level of regulation in the control of peptidase activity linked to cell growth, and provides new insights into how deubiquitination can play a major regulatory role in growth-associated cellular processes. Overall the experimental work is of a good standard, and the data presented support the conclusions drawn. The paper is well written, and the figures are clear.

Reviewer \#3:

The manuscript by Vanhaeren and co-authors describes a potential regulatory link between Arabidopsis UBP12 and UBP13 deubiquitinases and the ubiquitin-dependent peptidases DA1, DAR1 and DAR2 (termed DAs hereafter) to fine tune leaf growth and development. It has been proven that monoubiquitination at multiple sites of DA proteins, mediated by E3 ubiquitin ligases BIG BROTHER and DA2, is crucial to activate the DA peptidases, which in turn will cleave key leaf growth regulators, such as UBP15, TCP14, TCP15 and TCP22. Therefore, by identifying a mechanism to counteract DA activation, based on DA deubiquitination, the authors provide new insights on the regulatory networks that modulate the duration of cell proliferation and the transition to endoreduplication and differentiation during leaf formation. In this context, their findings have additional clear implications for crop improvement.

However, despite the relevance and interest of these findings, a number of issues should be addressed to substantiate the model proposed by the authors.

First, whereas biochemical evidence is provided about UBP12 and UBP13 deubiquitinating activity towards DA proteins (Figure 4), in vivo data supporting these results is completely missing. The levels of ubiquitinated DA proteins should be analyzed in plants with altered expression of UBP12 and UBP13 (described in this manuscript).

Second, information about protein-protein interaction between UBP12 and UBP13 and DA proteins is limited to immunoprecipitation-MS data. Such results should be confirmed by additional means that also describe where, at the cellular and subcellular level, those interactions occur (nuclei?).

Third, UBP12 and UBP13 are known to deubiquitinate several, in principle unrelated, targets. However, it remains unknown which mechanisms provide them specificity to recognize a specific set of ubiquitinated targets (i.e. DAs) in order to modulate their activity. Thus, the authors should provide evidence on the precise environmental and developmental conditions, and the signaling mechanisms involved, that trigger UBP12 and UBP13 function towards DAs.

Fourth, reduced and increased activity of UBP12 and UBP13 in *ubp12-2* mutants and overexpression lines, respectively, lead to similar leaf and seedling phenotypes (Figure 2, Figure 2---figure supplement 8, summarized in Figure 6). Indeed, in the Discussion section (third paragraph) the authors mention that high levels of UBP12 and UBP13 lead to a severe reduction in cell size. On the other hand, low levels of UBP12 and UBP13 reduce cell area. This is counterintuitive. A more detailed discussion should be provided to better explain the outputs of UBP12 and UBP13 function in balancing DA protein activation/inactivation in order to control plant development.

Fifth, in the last paragraph of the subsection "Overexpression of UBP12 or UBP13 delays the onset of endoreduplication", and Figure 3 and Figure 3---figure supplements 3 and 4, the authors show that overexpression of UBP12 and UBP13 induces expression, at certain time points, of several genes that positively regulate growth. This is contrary to the plant phenotype for those lines, where growth is reduced. These contradictory results should be discussed.

Sixth, Figure 4C. UBP12- and UBP13-mediated deubiquitination of ubiquitinated DAR2 is not clear at all, compared to that of ubiquitinated DA1 and DAR1. In addition, the fact that the shifted band with higher MW, corresponds indeed to ubiquitinated DA proteins should be proven (showing the in vitro DA2-mediated ubiquitination assays with appropriate controls).
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Author response

> The reviewers appreciated the mechanistic advance of your work, unraveling the regulatory importance of UBPs for the ubiquitin-dependent regulation of DA1, DAR1, and DAR2. However, they request that you should further consolidate your core findings prior publication at eLife. Mandatory requests include:
>
> 1\) Please, provide a confirmation of the physical interaction of UBPs and DAs through another method.

In the submitted manuscript, we had demonstrated the interaction between DA1, DAR1 and DAR2 with an in vivo IP-MS/MS, using Arabidopsis seedlings. This interaction was also confirmed by the in vitro deubiquitination assay. To further confirm these interactions, we performed an in vitro pull-down using recombinant GST, GST-UBP12 or GST-UBP13 as baits proteins, and HIS-MBP-DA1, HISMBP-DAR1 or HIS-MBP-DAR2 as prey proteins. After incubation and washing, our Western blots showed a strong interaction with GST-UBP12/13 and the prey proteins (HIS-MBP-DA1, HIS-MBP-DAR1 and HIS-MBP-DAR2), but not in the negative control (Figure 1D, E and F).

In addition, we performed an additional in vivo IP in Arabidopsis cell suspension cultures. For this purpose, full expression constructs of *35S::RFP-DA1, 35S::RFP-DAR1, 35S::RFP-DAR2, 35S::GFP-UBP12* and *35S::GFP* were amplified by PCR and cloned into golden gate modules using the Gibson assembly method. Existing *bsaI* sites in the Gateway p35S sequence and the *DAR1* coding sequence were mutated by site-directed mutagenesis using *dpnI* to make the constructs compatible for Golden Gate cloning. Subsequently, these constructs were cloned as interaction pairs on a Golden Gate vector to ensure the co-expression of the constructs in each cell. After an IP and WB, the interaction between GFP-UBP12 and RFP-DA1, RFP-DAR1 and RFP-DAR2 could be confirmed (Figure 1G).

The Materials and methods section has been updated.

> 2\) Please, illustrate the differences in the level of DA1 ubiquitination depending on UBP12 and UBP13 activity.

In the original manuscript, in vitro evidence of the deubiquitination of the DA proteins by UBP12 and UBP13 was provided. in vivo in Arabidopsis, DA1 is a very lowly abundant protein which can only be visualized after IP ((Vanhaeren et al., 2017); Supplementary Figure 3D). In addition, in vivo ubiquitination of DA1 is very challenging to demonstrate. In the past, we extensively attempted to co-express GFP-DA1 with either BB or DA2, but we could never demonstrate an ubiquitination event by Western blotting. Only by adding high amounts of TR-TUBEs, synthetic proteins that specifically bind ubiquitin and might therefore stabilize this post-translational modification, to the extract of *35S::GFPDA1* during the extraction, it was possible to visualize ubiquitination patterns of GFP-DA1 in vivo (Dong et al., 2017). However, the process of adding TR-TUBEs to the extract followed by an immunoprecipitation, combined with the dramatic phenotypic differences between *35S::GFP_DA1* and *35S::GFP-DA1_35S::UBP12/13* plants might however induce a lot of variability. This could complicate a proper quantification of the deubiquitination of DA1. In addition, only limited seed material was available to perform these experiments due to fertility issues of the *35S::UBP12/13* lines, as is mentioned in the original manuscript.

Therefore, we applied an alternative approach based on well-established cell-free degradation approaches (Cheng et al., 2017; Dong et al., 2017; Garcia-Cano et al., 2014). Is such assays, fixed amounts of recombinant proteins are incubated with cell-free extracts of plants and their stability can be visualize over time by Western blot. Similarly, we started from exactly the same amount of ubiquitinated proteins that could be monitored over time. As starting material, newly prepared protein extracts (without protease inhibitors) of 8-day old seedlings of Col-0, *ubp12-2, 35S::UBP12* and *35S::UBP13*, that contained different levels of UBP12 and UBP13, were used. Subsequently, 400µg of cell-free extract was added per 200ng ubiquitinated HIS-MBP-DA1 proteins. From this reaction mix, equal amounts were taken per time point and deubiquitination was stopped by the addition of SDS-containing buffer. The samples were then subjected to Western blot and detection was done with anti-MBP. To quantify deubiquitination, a rectangle was drawn in ImageJ spanning the size of fully ubiquitinated HIS-MBP-DA1. Then, the lane intensities were plotted and the pixels within the resulting curves were measured.

In the Western blots shown in Figure 5A, we can clearly observe a rapid decrease in molecular weight of the HIS-MBP-DA1 proteins after addition of Col-0 extract (Figure 5A), which was not observed when *ubp12-2* extract was added (Figure 5B-C).

Next, we performed a similar experiment that also included the overexpression lines, which have high levels of UBP12 or UBP13. First, we could observe again that a slower rate of deubiquitination in samples where *ubp12-2* extract was added compared to those with Col-0 (Figure 5D-E). To be as stringent as possible, the stronger HIS-MBP-DA1 band of the *ubp12-2* Western blot at 0 h (Figure 5E, lane 7) was taken to calculate the deubiquitination (see Figure 5---source data 1: Calculation of in vivo deubiquitination). For the other blots, the average of the two 0 h lanes were taken. In contrast with the slower deubiquitination with *ubp12-2* extract, a faster loss of the ubiquitinated HIS-MBP-DA1 was observed when an extract of *35S::UBP12* or *35S::UBP13* plants was added compared to Col-0 (Figure 5F-H).

Taken together, these experiments demonstrate that the level of DA1 deubiquitination depends on different in planta levels of UBP12 and UBP13 and strengthen the validity of the in vitro experiments. These data were included as Figure 5 in the manuscript and an additional Source data file containing the plots and measurements was added.

> 3\) Please, revise the model at the end so it only reflects what has definitely been shown in this (and previous) studies.

We have indicated in the model in a graphical manner what was demonstrated phenotypically (Figure 7, top panel) and molecularly (Figure 7, middle panel) in this study, and what the potential outcomes on the substrates of DA1 are, based on published work (Figure 7, bottom panel).

In addition, we added an updated model of the complete molecular mode of action of the entire pathway, adding the results from this manuscript to the knowledge from previous studies. This figure (in high resolution) was added as Figure 7---figure supplement 1 in the manuscript.

> 4\) To complement the in vitro evidence, the reviewers kindly ask to possibly test whether overexpression or downregulation of UBP12/3 indeed affect DA1/DAR1/2 peptidase activity and thereby impact cleavage or protein stability of UBP15 and TCPs in protoplasts.

To address this challenging request, we aimed to generate an in vivo situation with high levels of ubiquitinated DA1, which could then be counteracted by either UBP12, UBP13 and their respective catalytically dead mutants. For this purpose, we generated the following expression constructs:

1\) *35S::RFP-DA1* and *35S::DA2-FLAG* to generate ubiquitinated DA1

2\) *p35S::GFP-UBP12* and *p35S::GFP-UBP13* as inhibitors of DA1 activity and *p35S::GFP-UBP12^C208S^* and *p35S::GFP-UBP13^C207S^* as the respective negative controls

3\) *pUBP10::HA-TCP14*, *pUBP10::HA-TCP15, pUBP10::HA-TCP22, pUBP10::HA-UBP15* and *pUBP10::HA-BB* as cleaving substrates

The following setup was used (only one substrate is shown) to detect cleaving by DA1 and inhibition of cleaving by UBP12 or UBP13.

  *35S::RFP-DA1*   *35S::DA2-FLAG*   *p35S::GFP-UBP12*          pUBQ10::HA-BB   Cleaving inhibition
  ---------------- ----------------- -------------------------- --------------- ---------------------
  *35S::RFP-DA1*   *35S::DA2-FLAG*   *p35S::GFP-UBP12^C208S^*   pUBQ10::HA-BB   Cleaving
  *35S::RFP-DA1*   *35S::DA2-FLAG*   *p35S::GFP-UBP13*          pUBQ10::HA-BB   Cleaving inhibition
  *35S::RFP-DA1*   *35S::DA2-FLAG*   *p35S::GFP-UBP13^C207S^*   pUBQ10::HA-BB   Cleaving

Next, protoplasts were transformed with these four constructs and the cleavage of the substrate was used as a readout of DA1 activity. Unfortunately and despite numerous attempts, we were unable to simultaneously express all four constructs in protoplasts of either BY-2 cells, Arabidopsis mesophyll cells or Arabidopsis cell suspension culture cells.

To ensure a better simultaneous transformation (and hence expression) and in an attempt to enhance the detection sensitivity, we then generated the following constructs:

1\) *35S::HA-DA1* and *35S::DA2-FLAG* to generate ubiquitinated DA1

2\) *pUBP10::UBP12-BFP* and *pUBP10::UBP13-BFP* as inhibitors of DA1 activity and *pUBP10::UBP12^C208S^--BFP* and *pUBP10::UBP13^C207S^--BFP* as the respective negative controls

3\) *pUBP10::NLS-GFP-TCP14-mCherry*, *pUBP10::NLS-GFP-TCP15-mCherry, pUBP10::NLS-GFPTCP22-mCherry, pUBP10::NLS-GFP-BB-mCherry* as cleaving substrates

These constructs of the cleaving substrates would allow us to detect the cleaving and inhibition of cleaving with confocal microscopy by measuring the differences of FRET, and hence cleaving of the substrate, in the presence of UBP12/13 compared to their catalytic mutants.

Because a simultaneous expression of these constructs in each cell is required, these constructs were amplified by PCR and cloned into Golden Gate modules (pGGA000, pGGB000, pGGC000, pGGD000) using the Gibson assembly method (NEB, E5510S). The sequences were verified and existing *bsaI* sites in the gateway p35S and coding sequences were mutated by site-directed mutagenesis using *dpnI* to make the constructs compatible for Golden Gate cloning. Subsequently, these constructs were cloned as multiple expression modules in a small Golden Gate vector (pGG-AG-kan). A schematic representation of a set of these modules can be found in [Author response table 2](#resptable2){ref-type="table"}:

  *35S::HA-DA1*   *35S::DA2-FLAG*   *pUBP10::UBP12-BFP*           *pUBP10::NLS-GFP-TCP14-mCherry*   Cleaving inhibition, FRET
  --------------- ----------------- ----------------------------- --------------------------------- ---------------------------
  *35S::HA-DA1*   *35S::DA2-FLAG*   *pUBP10::UBP12^C208S^--BFP*   *pUBP10::NLS-GFP-TCP14-mCherry*   Cleaving, loss of FRET
  *35S::HA-DA1*   *35S::DA2-FLAG*   *pUBP10::UBP13-BFP*           *pUBP10::NLS-GFP-TCP14-mCherry*   Cleaving inhibition, FRET
  *35S::HA-DA1*   *35S::DA2-FLAG*   *pUBP10::UBP13^C208S^--BFP*   *pUBP10::NLS-GFP-TCP14-mCherry*   Cleaving, loss of FRET

Unfortunately and despite a large amount of work using protoplasts of BY-2 cells and Arabidopsis cell suspension culture cells, no fluorescent signal could be observed in these cells (after 12, 24 or 48 hours).

Additional requests:

We performed additional experiments to address the additional comments and suggestions of the reviewers. The suggested textual changes were applied and size bars were added where necessary.

> Please provide an image or a reference for the leaf roundness of da1-1 plants and plants overexpressing UBP12 or UBP13.

We have measured the height and width of Col-0, *da1-1, 35S::UBP12* and *35S::UBP13* leaves and calculated the leaf index. The leaf index is the ratio of leaf height to width and hence a measure of leaf shape (Tsukaya, 2002). We found that the leaf index of *da1-1, 35S::UBP12* and *35S::UBP13* leaves was consistently smaller than that of Col-0, meaning the leaves have a rounder shape.

These figures were included as Figure 2---figure supplements 1-2 in the manuscript, the raw data and statistical analysis are added as Figure 2---source data 2.

> Please test if the stability of DA1 is affected by the presence of high levels of UBP12 and UBP13 in vivo by Western blot.

We have extracted proteins of *35S::GFP-DA1, 35S::GFP-DA1_35S::UBP12* and *35S::GFPDA1_35S::UBP13* plants and performed a purification with anti-GFP beads from equal protein inputs. After purification, we submitted the samples to Western blot and detected the abundance of GFP-DA1 proteins. We could not identify dramatic increases in protein abundance in the *35S::GFPDA1_35S::UBP12* and *35S::GFP-DA1_35S::UBP13* samples compared to those of *35S::GFP-DA1*, suggesting UBP12 and UBP13 do not prevent potential removal of polyubiquitin chains of DA1 and hereby prevent its degradation by the proteasome.

This figure was added as Figure 5---figure supplement 1 in the manuscript.

> Please frame the new findings of UBP12 and UBP13 limiting the activity of DA1 with the additional activation-destruction system of the E3-ligases.

This dual control system is indeed important to restrict the levels of activated DA1. Because DA1 is a negative regulator of growth, these mechanisms are pivotal to keep the balance between active and inactive DA1 and coordinate developmental transitions without compromising growth. We have now addressed this more elaborate in the Discussion section.

> Reduced and increased levels of UBP12 and UBP13 lead to a reduction in cell area and leaf size, this counterintuitive observation should be addressed in more detail.

We agree this observation might be counterintuitive. Parallels can be found however with triple mutants of DA1, DAR1 and DAR2 (*da1ko_dar1-1_dar2-1*; (Peng et al., 2015)) and overexpression lines of *GFP-DA1* (Vanhaeren et al., 2017). Both lines have contrasting levels of DA1, but produce smaller leaves. Our and previous studies suggest that a tightly controlled balance of activated DA1 is required for a correct developmental switch from cell proliferation to cell differentiation and endoreduplication. If too few ubiquitinated DA1 (DAR1, DAR2) is present, this developmental switch is delayed or severely disturbed and plants are smaller. If, on the other hand, the levels of activated DA1 are too high, too many downstream growth regulators might be cleaved, resulting in a reduction of cell division.

We further elaborated this in the Discussion section of the manuscript.

> The authors show that overexpression of UBP12 and UBP13 induces expression, at certain time points, of several genes that positively regulate growth. This is contrary to the plant phenotype for those lines, where growth is reduced. These contradictory results should be discussed.

We agree that the higher levels of positive regulators of growth during the younger stages of leaf development of *35S::UBP12* and *35S::UBP13* plants are contradictory with their smaller phenotypes. Many genes that were selected are markers of cell proliferation and their ectopic expression indeed results in an increase in final cell number and leaf size. Most importantly, these genes also show a specific expression pattern during the transition of cell proliferation (high expression) to cell expansion (low expression). It is for the latter reason that these genes were selected. This allowed us to confirm our flow cytometry data, which showed that the leaf tissue of *35S::UBP12* and *35S::UBP13* plants was in a more proliferative stage (high expression of these marker genes and more 2C and 4C) than those of the Col-0 (lower expression of these marker genes and more 8C). We also made additional cell drawings of the tip of leaves during this developmental transition from cell proliferation to expansion (12 DAS, (Andriankaja et al., 2012)). We could observe that the cells in Col0 leaves clearly started expanding and differentiating, whereas the leaf tips of *35S::UBP12* or *35S::UBP13* plants contained almost exclusively undifferentiated cells (see Figure 3D). These results, together with our observation that cell number was not significantly altered in *UBP12* an *UBP13* overexpression lines, indicate that especially during the early developmental stages of leaf growth, endoreduplication and cell differentiation are delayed in *35S::UBP12* and *35S::UBP13* leaves.

We rephrased the choice for these Q-RT-PCR genes and elaborated the interpretation of the data more extensively in manuscript and added the cellular data to the Results section.

> Please, describe where, at the cellular and subcellular level, the interaction between DA1, DAR1, DAR2 and UBP12, UBP13 occur.

We transiently expressed combinations of 35S::RFP-DA1, 35S::RFP-DAR1, 35S::RFP-DAR2 and 35S::GFP-UBP12, GFP-UBP13 in *Nicotiana benthamiana* leaves. Using confocal microscopy we could show that these proteins co-localize in the cytoplasm and in the nucleus (see Figure 7---figure supplements 5-10).
